Last reviewed · How we verify
NCT05139212
Determination of Optimum Time for Intravenous Cannulation in Children With Dexmedetomidine Premedication
trial testing Optimum time for intravenous cannulation in children premedicated with dexmedetomidine in Cannulation in 40 participants. Completed in 4 February 2022.
4 February 2022
Quick facts
| Lead sponsor | Karaman Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 2 December 2021 |
| Primary completion | 4 February 2022 |
| Estimated completion | 4 February 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Optimum time for intravenous cannulation in children premedicated with dexmedetomidine
Conditions studied
- Cannulation — all drugs for Cannulation →
- Sevoflurane Induction — all drugs for Sevoflurane Induction →
- Dexmedetomidine — all drugs for Dexmedetomidine →
Sponsor
Karaman Training and Research Hospital
Who can join
Adults 2 to 6, any sex, with Cannulation or Sevoflurane Induction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Inhalational induction with sevoflurane, nitrous oxide, and oxygen is accepted as a safe technique to avoid any movement during intravenous cannulation in children. In addition, intranasal dexmedetomidine could be used for premedication to reduce preoperative anxiety in preschool children. Early attempts to place, an intravenous line may result in movement and respiratory complications like coughing or laryngospasm. On the other hand delay in cannulation may prevent effective management of bradycardia and hypotension. There are a number of studies examining the optimum time for cannulation after sevoflurane induction. However, it is not known whether the addition of dexmedetomidine premedication affects the time for intravenous cannulation following induction with sevoflurane and nitrous oxide.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05139212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cannulation
Currently open trials in the same condition.
- NCT07354841 — Safety and Performance Evaluation of CPB Venous and Arterial Cannulas · NA · recruiting
Other Karaman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07130552 — Comparison of Distal IPACK and Popliteal Plexus Block Combined With Femoral Triangle Block After Total Knee Arthroplasty · NA · recruiting
- NCT07102407 — Effect of a Constructivist Educational Program on Preventing Ventilator-Associated Pneumonia in Intensive Care Units · NA · recruiting
- NCT06616740 — Effects of Paratracheal Compression and Cricoid Compression on LMA ProSeal Placement · NA · completed
- NCT06605937 — The Effect of Postoperative Eustachian Milking Maneuver on Eustachian Tube Dysfunction · completed
- NCT06634680 — Effects of Different Parental Involvement on Anxiety and Delirium · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05139212 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karaman Training and Research Hospital
- Last refreshed: 7 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05139212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing